BMPR2 and chronic thromboembolic pulmonary hypertension: The role of genetic variants of bone morphogenic protein type II receptor (BMPR2) and angiotensin-converting enzyme (ACE) in CTEPH was suggested in previous studies; however, their significance is still controversial [62,63].